Lowering the linoleic acid to alpha-linoleic acid ratio decreases the production of inflammatory mediators by cultured human endothelial cells.
Anti-Inflammatory Agents
/ pharmacology
Cell Survival
/ drug effects
Cells, Cultured
Endothelial Cells
/ metabolism
Humans
Inflammation Mediators
/ metabolism
Linear Models
Osmolar Concentration
Signal Transduction
/ drug effects
Tumor Necrosis Factor-alpha
/ pharmacology
alpha-Linolenic Acid
/ metabolism
Alpha-linolenic acid
Cytokine
Inflammation
Linoleic acid
n-6:n-3 ratio
Journal
Prostaglandins, leukotrienes, and essential fatty acids
ISSN: 1532-2823
Titre abrégé: Prostaglandins Leukot Essent Fatty Acids
Pays: Scotland
ID NLM: 8802730
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
05
11
2018
revised:
07
12
2018
accepted:
11
12
2018
entrez:
22
1
2019
pubmed:
22
1
2019
medline:
27
2
2020
Statut:
ppublish
Résumé
Alpha-linolenic acid (ALA) and linoleic acid (LA) are precursors for longer-chain more unsaturated fatty acids and for lipid signalling molecules that may influence inflammatory processes through a variety of mechanisms. The actions of LA and ALA may be divergent and interdependent. The aim of this study was to investigate the incorporation and metabolism of ALA and LA in cultured in EA.hy926 endothelial cells and the production of inflammatory mediators (VEGF, RANTES, ICAM-1, MCP-1, IL-6 and IL-8) by these cells when exposed to different concentrations of ALA, LA and ratios of LA:ALA. Human endothelial cells were cultured with either culture medium or culture medium supplemented with ALA, LA or various ratios of LA:ALA (1:4, 1:1, 4:1, 9:1 or 19:1) followed by 24 h TNF-α stimulation; the total concentration of ALA plus LA was kept constant at 100 μM. The incorporation and metabolism of ALA and LA was measured using gas chromatography. The production of inflammatory mediators in the supernatant was assessed using a Luminex Multi-Analyte kit. Both ALA and LA were incorporated and metabolised by the endothelial cells. Cells incubated with ALA had a statistically significantly lower production of VEGF, RANTES, ICAM-1, MCP-1 and IL-6 compared to cells incubated without additional ALA. LA was not found to exert pro-inflammatory effects. Cells incubated with low LA:ALA ratios had lower production of VEGF, RANTES, MCP-1 and IL-6 when compared with a LA:ALA ratio of 19:1. These findings suggest that a low LA:ALA ratio exerts anti-inflammatory effects by lowering the production VEGF, RANTES, ICAM-1, MCP-1 and IL-6 in TNF-α stimulated endothelial cells compared to a high ratio. These effects were likely mediated by ALA, but LA may also possess some anti-inflammatory effects.
Identifiants
pubmed: 30661600
pii: S0952-3278(18)30245-X
doi: 10.1016/j.plefa.2018.12.001
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Inflammation Mediators
0
Tumor Necrosis Factor-alpha
0
alpha-Linolenic Acid
0RBV727H71
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-8Subventions
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.